OTTAWA, August 13, 2026, 16:06 EDT — U.S. markets closed.
DEFSEC Technologies Inc. NASDAQ:DFSC surged 86.3% on Thursday after quarterly revenue nearly doubled. Yet the close remained below its June financing price.
The defense-technology stock ended at $2.31, up from $1.24. It traded 109.3 million shares, roughly 972 times Wednesday’s volume. That turnover equaled about 41 times the 2.67 million shares outstanding on July 20. Repeated trading of the same shares can inflate that ratio.
The scale of the activity is the key investor signal. Buyers responded to faster sales and fresh U.S. Army testing. But the late retreat from a $3.57 intraday high showed how quickly enthusiasm cooled.
| Market measure | August 13 | Comparison |
|---|---|---|
| Close | $2.31 | +86.3% daily |
| Intraday range | $2.08-$3.57 | 72% span from low |
| Volume | 109.3 million | 972x prior session |
| Latest disclosed shares | 2.67 million | 41x turnover |
Revenue reached C$2.72 million in the fiscal third quarter. That was 92% above a year earlier. Government-program digitization revenue climbed 121%, according to Thursday’s filing.
| Fiscal Q3, C$ millions | 2026 | 2025 | Change |
|---|---|---|---|
| Revenue | 2.72 | 1.42 | +92% |
| Gross margin dollars | 0.90 | 0.40 | +126% |
| Gross margin rate | 33.1% | 28.2% | +4.9 points |
| Adjusted EBITDA loss | (1.94) | (1.49) | Loss widened 30% |
The growth did not yet cover the cost base. Operating expenses rose to C$3.46 million from C$2.22 million. The adjusted EBITDA loss widened by about C$451,000. The measure is unaudited and non-IFRS.
President and CEO Sean Homuth called the defense-software growth evidence of a more predictable revenue base. He also said U.S. Army testing validated the BLISS product roadmap. Those statements describe management’s view, not an order commitment.
DEFSEC completed BLISS testing for one U.S. Army vehicle program. A separate Army office invited the company to an evaluation in late August. No contract value or purchase order was disclosed.
| Balance-sheet measure, C$ millions | June 30, 2026 | September 30, 2025 | Change |
|---|---|---|---|
| Cash and short-term investments | 3.53 | 6.73 | -48% |
| Receivables | 2.31 | 1.49 | +55% |
| Working capital | 3.67 | 6.03 | -39% |
| Total liabilities | 5.34 | 5.12 | +4% |
Cash and short-term investments fell 48% over nine months. A June financing added C$2.5 million gross after quarter-end. DEFSEC sold 673,006 shares at US$2.63 each, with an equal number of five-year warrants.
Thursday’s $3.57 high cleared that offering price by 35.7%. The $2.31 close sat 12.2% below it. The new shares increased the count by about 33.8%. A separate registration covers up to 723,481 warrant shares, equal to 27.1% of the latest outstanding count.
| Analyst recommendation measure | Publicly available reading | Investor use |
|---|---|---|
| Consensus rating | Not available | No broad sell-side benchmark |
| Average price target | Not available | No target-based upside estimate |
| Tracked recommendations | None listed | Price discovery rests mainly on filings and trading |
No public analyst consensus or price target was available for DFSC. That absence matters for a micro-cap with extreme turnover. Investors have little external earnings framework for separating product progress from speculative demand.
Risks remain high. Revenue is growing from a small base, losses widened, and cash declined before the June raise. Army evaluations may not produce orders. Registered warrant shares could also add supply.
The next evidence point is the late-August BLISS evaluation. Investors will need contract size, timing and cash conversion—not testing alone—to justify a lasting rerating.
Related articles: Earnings
